Literature DB >> 11412879

Color vision deficiencies in Gilles de la Tourette syndrome.

J P Melun1, L M Morin, J G Muise, M DesRosiers.   

Abstract

Color perception was tested using the Farnsworth-Munsell 100-Hue Test in a sample of persons with Gilles de la Tourette syndrome (GTS), and compared to norms from three age cohorts in the early second, fourth and sixth decades. Red-green color errors on the Farnsworth-Munsell did not appear to change appreciably as a function of age or GTS. Blue-yellow error scores did, however, increase with age and were exaggerated in the GTS group. It is concluded that sensory and perceptual disturbances are present in GTS as in other basal cell ganglia disorders. The results are discussed in terms of converging retinal dopaminergic mechanisms also associated with Parkinson's and Huntington's diseases and even with normal aging. Suggestions are offered that daily activities and behavior may be affected by spatial and chromatic deficiencies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11412879     DOI: 10.1016/s0022-510x(01)00516-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  A case of bilateral self-induced keratoconus in a patient with tourette syndrome associated with compulsive eye rubbing: case report.

Authors:  Artemios Kandarakis; Michael Karampelas; Vasileios Soumplis; Christos Panos; Nikolaos Makris; Stylianos Kandarakis; Dimitrios Karagiannis
Journal:  BMC Ophthalmol       Date:  2011-09-21       Impact factor: 2.209

2.  Novel n-back spatial working memory task using eye movement response.

Authors:  Cameron B Jeter; Saumil S Patel; Anne B Sereno
Journal:  Behav Res Methods       Date:  2011-09

3.  Color perception deficits in co-existing attention-deficit/hyperactivity disorder and chronic tic disorders.

Authors:  V Roessner; T Banaschewski; A Fillmer-Otte; A Becker; B Albrecht; H Uebel; J Sergeant; R Tannock; A Rothenberger
Journal:  J Neural Transm (Vienna)       Date:  2007-09-27       Impact factor: 3.575

4.  Color naming deficits and attention-deficit/hyperactivity disorder: a retinal dopaminergic hypothesis.

Authors:  Rosemary Tannock; Tobias Banaschewski; David Gold
Journal:  Behav Brain Funct       Date:  2006-01-27       Impact factor: 3.759

5.  Centrality of prefrontal and motor preparation cortices to Tourette Syndrome revealed by meta-analysis of task-based neuroimaging studies.

Authors:  Liliana Polyanska; Hugo D Critchley; Charlotte L Rae
Journal:  Neuroimage Clin       Date:  2017-08-03       Impact factor: 4.881

6.  Corneal cross-linking for keratoconus caused by compulsive eye rubbing in patients with Tourette syndrome: Three case reports.

Authors:  Megumi Shinzawa; Naoko Kato; Kozue Kasai; Kenji Konomi; Yuzhu Chai; Jun Shimazaki
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Attentional blink and putative noninvasive dopamine markers: Two experiments to consolidate possible associations.

Authors:  Anne Charlotte Trutti; Zsuzsika Sjoerds; Bernhard Hommel
Journal:  Cogn Affect Behav Neurosci       Date:  2019-12       Impact factor: 3.282

8.  Color and contrast vision in mouse models of aging and Alzheimer's disease using a novel visual-stimuli four-arm maze.

Authors:  Jean-Philippe Vit; Dieu-Trang Fuchs; Ariel Angel; Aharon Levy; Itschak Lamensdorf; Keith L Black; Yosef Koronyo; Maya Koronyo-Hamaoui
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

9.  Does methylphenidate treatment affect functional and structural ocular parameters in patients with attention deficit hyperactivity disorder? - A prospective, one year follow-up study.

Authors:  Pınar Bingöl-Kızıltunç; Esra Yürümez; Huban Atilla
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

10.  Effects of estrogen on higher-order cognitive functions in unstressed human females may depend on individual variation in dopamine baseline levels.

Authors:  Lorenza S Colzato; Bernhard Hommel
Journal:  Front Neurosci       Date:  2014-04-07       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.